Sensible Medicine
APRIL 14, 2024
In fact, the FDA’s accelerated approval won’t grant access to new drugs, but rather, I fear, is a grand strategy to force insurers and Medicare to pay for these uncertain drugs. Some speakers represented patient advocacy organizations and later lashed out at me on twitter.
Guideway Care
JANUARY 14, 2025
In bundled payment models, patient advocacy plays a pivotal role in improving care coordination, patient satisfaction, and adherence to treatment plans. This blog explores how patient advocacy enhances care quality, addresses social determinants of health, and supports bundled payment success.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
MARCH 4, 2021
In 2021, patients-as-health-consumers seek lower health care and prescription drug costs coupled with higher quality care, discovered by the patient advocacy coalition, Consumers for Quality Care. A major side-effect of the coronavirus pandemic in 2020 was its impact on the national U.S. population). population).
Scrubs
MAY 18, 2024
These patients face unique challenges, from high medical costs to limited access to necessary treatments. Nurses in these settings play a pivotal role in providing medical care and guiding patients through the complexities of the healthcare system without insurance.
Health Populi
FEBRUARY 5, 2020
Americans who have commercial health insurance (say, through an employer or union) are rarely thought to face barriers to receiving health care — in particular, primary care, that front line provider and on-ramp to the health care system. visits per 100 member-years.
Health Populi
MARCH 4, 2021
In 2021, patients-as-health-consumers seek lower health care and prescription drug costs coupled with higher quality care, discovered by the patient advocacy coalition, Consumers for Quality Care. A major side-effect of the coronavirus pandemic in 2020 was its impact on the national U.S. population). population).
ACMA Blog
JULY 9, 2024
Given the current state of PBM dominance, pharmacists, health insurers, and drug manufacturers often have little choice but to interact with the large, dominant PBMs when distributing certain drugs. PBMs may also use narrow networks to channel patients into their own affiliated pharmacies, even if competitors offer drugs at the same prices.
Expert insights. Personalized for you.
363 
Let's personalize your content